Skip to content
ChinaCSR.com logo

Corporate Social Responsibility & Sustainability in China

Corporate Social Responsibility in China

China Suspends Rabies Vaccine Production At Two Manufacturers

December 10, 2009
-
Health

China's State Food and Drug Administration has suspended the production and sales activities of two companies whose rabies vaccine products were found to be substandard.

The two companies are reported to be Jiangsu Yanshen Biological Stock Company and Forwell Biopharm Company. SFDA said that seven batches of the rabies vaccines for human use which were produced by the two between July and October of 2008 have quality problems. It is learned that these substandard vaccines have already been sold in 27 provinces and regions in China, including Shanxi, Henan, Hainan, Hebei, Anhui, Zhejiang, and Shandong.

So far, SFDA has sent an inspection team to investigate the two companies and the local food and drug departments of the two regions have also organized experts to evaluate the risks caused by the vaccines. They say they will punish the vaccine manufacturers based on the outcome of the investigation.

SFDA has stated that people who have already used these said vaccines can consult with their local vaccination department.

Tags: Anhui, Forwell Biopharm Company, Hainan, Hebei, Henan, Jiangsu Yanshen Biological Stock Company, rabies, SFDA, Shandong, Shanxi, substandard, vaccine, Zhejiang

Readers also read this:

Caterpillar China R&D Center Gets LEED Gold Certification

November 16, 2010

China Province To Eliminate Disposable Amenities From Hotels

November 5, 2010

Unilever China Wins China Green Gold Award

November 4, 2010

ZTE Organizes CSR Conference In Sanya

November 3, 2010

ADB And Tongji University Establish Urban Knowledge Hub

November 2, 2010

Yingli Green Energy Expands Production Capacity

November 1, 2010
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文
Menu
  • About Us
  • Contact Us
  • Corrections and Disclosure Policy
  • Privacy Policy
  • Terms & Conditions
  • 中文

Copyright 2023 © ChinaCSR.com. All Rights Reserved. A service of Asia Media Network. If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website for commercial purposes created by ChinaCSR.com, in whole or in part, is expressly prohibited without express written permission from ChinaCSR.com. Individual news stories curated from other sources are copyright their respective sources.

Asia Media Network